5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 31.79▲ | 31.76▲ | 31.67▲ | 30.55▲ | 29.42▲ |
MA10 | 31.65▲ | 31.61▲ | 31.68▲ | 29.41▲ | 24.55▲ |
MA20 | 31.34▲ | 31.06▲ | 30.80▲ | 28.86▲ | 17.17▲ |
MA50 | 30.53▲ | 30.02▲ | 29.44▲ | 22.87▲ | 12.28▲ |
MA100 | 29.36▲ | 28.77▲ | 28.69▲ | 16.25▲ | 13.83▲ |
MA200 | 28.58▲ | 28.85▲ | 27.10▲ | 12.72▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | 0.006▲ | 0.036▲ | -0.083▼ | 1.797▲ |
RSI | 62.509▲ | 62.626▲ | 63.014▲ | 66.999▲ | 84.169▲ |
STOCH | 62.414 | 51.051 | 61.479 | 83.759▲ | 82.213▲ |
WILL %R | -32.203 | -19.289▲ | -15.574▲ | -5.571▲ | -8.694▲ |
CCI | 66.662 | 72.419 | 69.844 | 162.600▲ | 88.474 |
Wednesday, April 24, 2024 01:08 PM
First Interstate BancSystem, Inc. (NASDAQ: FIBK) (the "Company") today reported financial results for the first quarter of 2024. For the quarter, the Company reported net income of $58.4 million, or ...
|
Wednesday, April 24, 2024 05:00 AM
FUROSCIX Auto-injector being developed as a complement to the FUROSCIX On-body Infusor Company anticipates topline data in Q3 2024, followed by a Supplemental New Drug Application (sNDA) by year-end ...
|
Wednesday, April 24, 2024 04:49 AM
First non-immunosuppressive therapy for the treatment of IgA nephropathy (IgAN) approved in EuropeConditional marketing authorization is based on ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
24/04/24 | 31.06 | 32.225 | 31.06 | 32.05 | 24,924 |
23/04/24 | 30.44 | 32.46 | 29.95 | 31.75 | 27,975 |
22/04/24 | 29.42 | 30.68 | 29.186 | 29.94 | 14,422 |
19/04/24 | 29.61 | 30.89 | 29.07 | 29.42 | 33,340 |
18/04/24 | 28.57 | 30.7899 | 28.55 | 29.61 | 30,065 |
17/04/24 | 27.70 | 29.34 | 27.23 | 28.65 | 34,014 |
16/04/24 | 28.88 | 28.97 | 26.895 | 27.70 | 29,075 |
15/04/24 | 27.46 | 28.91 | 27.46 | 28.88 | 29,443 |
12/04/24 | 28.08 | 28.11 | 27.01 | 28.00 | 23,068 |
11/04/24 | 27.00 | 28.40 | 26.16 | 28.08 | 23,987 |
|
|
||||
|
|
||||
|
|